Giorgia Guglielmi

Fever after cancer therapy may be linked to specific gut microbes

The findings of a new research suggest that dietary and antibacterial strategies may help to prevent neutropenia-related fever after cancer therapy.

Obese mice are protected against genital herpes — thanks to their microbiota

The findings of a new research suggest that obesity-induced changes in the vaginal microbiota can affect the immune responses against viral infection.

Two large studies link specific gut bacteria to depression

The findings of a new research support the link between gut microbes and depression, and suggest that the gut microbiota can be a target for future therapies.

Japanese gut metagenomes show microbial features associated with diet and disease

The findings of a japanese research suggest that several viruses are linked to specific populations and diseases.

Gut microbes may mediate beneficial effects of low-carb diet on irritable bowel syndrome

Researchers have found that a diet low in fermentable carbohydrates can alter the human microbiota in ways that influence the expression of genes involved in inflammation and intestinal integrity.

How the tumor microbiota may reduce the efficacy of cancer drugs

A recent study confirms that 5-FU exerts part of its anti-cancer effects through inhibiting the growth of F. nucleatum, the commensal associated with colorectal cancer progression.

A closer look at the microbiota of the small intestine

A recent study confirms that ileum and colon have a distinct microbiota: unlike the bacterial composition of the colon, the ileum is subject to frequent fluctuations.

Gut bacteria influence response to cocaine in mice

The findings of a new research may help to inform therapies to modulate brain circuits that are involved in substance use disorders.

COVID-19 may disrupt gut microbiota to increase risk for other infections

Microbiota alterations in COVID-19 patients appeared to be associated with secondary infections of the blood by gut bacteria: four cases of positive blood cultures of Staphylococcus species were identified.

DNA-damaging microbial metabolites found in people with inflammatory bowel disease

The findings of a recent study suggest that DNA damage-inducing microbial metabolites such as indolimines play a role in the development of colorectal cancer.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top